Beyond Meat Faces Critical Earnings Release Amid Accounting Woes and Nasdaq Threat

Today marks a pivotal moment for Beyond Meat as the company prepares to release its long-delayed fourth quarter and full-year 2025 financial results. The context for this earnings report is fraught with challenges, including accounting errors, a potential delisting from the Nasdaq, and a share price languishing near $0.61.

A Daunting Hurdle: Compliance and Credibility

The earnings release, originally postponed, follows the discovery of internal control deficiencies related to inventory valuation. Management identified errors impacting the first three quarters of 2025, which resulted in an understatement of cost of goods sold and a concurrent overstatement of inventory write-downs in Q3. While the company has stated these misstatements are not material to the overall financial picture, a formal review was initiated. The audited annual figures and the 10-K filing are expected today, accompanied by a conference call at 5:00 p.m. New York time.

Compounding these internal issues is a formal deficiency notice from the Nasdaq. The exchange issued the warning after Beyond Meat's stock traded below the mandatory $1.00 minimum bid price for over 30 consecutive trading days. To maintain its listing, the equity must close at or above $1.00 for a minimum of ten consecutive trading days by August 31, 2026. With shares currently around $0.61, this presents a significant obstacle. The stock has fallen approximately 77% from its 52-week high of $7.69.

Should investors sell immediately? Or is it worth buying Beyond Meat?

Institutional Interest Defies Gloomy Sentiment

Despite the bleak backdrop, recent regulatory filings reveal a notable surge in institutional ownership during Q4 2025. Institutional investors now hold roughly 52.5% of the company’s outstanding shares. Specific funds dramatically increased their stakes: Geode Capital Management grew its position by 445%, Charles Schwab Investment Management by 497%, and Virtu Financial by 670%.

Whether this represents opportunistic bargain-hunting or a strategic long-term conviction is unclear. The prevailing analyst consensus remains firmly negative, with a "Sell" rating. Six analysts recommend selling the stock, while two advise holding. Their average price targets range between $1.61 and $1.70 per share.

Market Expectations and Industry Headwinds

Options market activity implies traders are pricing in potential share price movement of up to 30% following the earnings announcement. Consensus estimates project Q4 revenue of approximately $63 million, which would represent an 18% decline year-over-year. The anticipated loss per share is between $0.10 and $0.12, with the full-year 2025 net loss forecast at around $237.7 million.

The company also faces a difficult industry climate. Competitor JBS has already warned of challenging conditions in the U.S. protein market for early 2026. These external pressures converge with Beyond Meat's ongoing internal efforts to rectify its accounting issues. The figures released after today's market close will ultimately reveal the true scale of the gap between expectation and reality for the embattled plant-based protein producer.

Ad

Beyond Meat Stock: New Analysis - 31 March

Fresh Beyond Meat information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Beyond Meat analysis...

US08862E1091 | BEYOND | boerse | 69033976 |